Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen
Autore:
Jung, S; Chung, YK; Chang, SH; Kim, J; Kim, HR; Jang, HS; Lee, JC; Chung, GH; Jang, YS;
Indirizzi:
Chonbuk Natl Univ, Div Biol Sci, Chonju 561756, South Korea Chonbuk Natl Univ Chonju South Korea 561756 , Chonju 561756, South Korea Chonbuk Natl Univ, Inst Mol Biol & Genet, Chonju 561756, South Korea Chonbuk Natl Univ Chonju South Korea 561756 , Chonju 561756, South Korea Korea Univ, Coll Med, Dept Dent Oral & Maxillofacial Surg, Ansan 425020, South Korea Korea Univ Ansan South Korea 425020 cial Surg, Ansan 425020, South Korea
Titolo Testata:
MOLECULES AND CELLS
fascicolo: 1, volume: 12, anno: 2001,
pagine: 41 - 49
SICI:
1016-8478(20010831)12:1<41:DIOG3O>2.0.ZU;2-Y
Fonte:
ISI
Lingua:
ENG
Soggetto:
MAJOR ENVELOPE GLYCOPROTEIN; PROTECTIVE IMMUNITY; PLASMID DNA; B-CELLS; NASOPHARYNGEAL CARCINOMA; NEUTRALIZING ANTIBODIES; HODGKINS-DISEASE; MEMBRANE ANTIGEN; SUBUNIT VACCINE; GENE-EXPRESSION;
Keywords:
antibody; cytotoxic T lymphocyte; DNA vaccine; Epstein-Barr virus; gp350;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
55
Recensione:
Indirizzi per estratti:
Indirizzo: Jang, YS Chonbuk Natl Univ, Div Biol Sci, Chonju 561756, South Korea Chonbuk Natl Univ Chonju South Korea 561756 561756, South Korea
Citazione:
S. Jung et al., "DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen", MOL CELLS, 12(1), 2001, pp. 41-49

Abstract

Epstein-Barr virus (EBV) is a human pathogen that is involved in numerous diseases and tumors. Since the EBV infection occurs in the early ages of life, and most of the population is subsequently exposed to EBV, the conventional method of vaccination to induce the prophylactic immunity cannot be considered effective in coping with the virus infection. In this study, we tested whether the injection of a plasmid vector that contained the gene for glycoprotein 350 (gp350), which had been identified as a ligand for virus' adsorption and a target for virus neutralizing antibodies, could induce effective immune responses against the antigen. As a result, the injection of the constructed plasmid vector into mice induced the production of gp350-specific antibodies. A major isotype of the gp350-specific antibodies was IgG1. The antibodies efficiently mediated the antibody-dependent cellular cytotoxicity against the cells expressing the gp350 antigen. In addition, the injection of the constructed plasmid vector stimulated the precursor T cell population that was specific to the gp350 antigen. In addition, gp350-specific cytotoxic T lymphocytes were efficiently stimulated by the injection ofthe constructed plasmid vector. These results suggested that the injectionof the plasmid vector, containing the gp350 gene of Epstein-Barr virus, could be one of the most effective ways to induce both prophylactic and therapeutic vaccinations against the virus infection.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 13:12:12